Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Endocr Pract. 2012 Sep-Oct;18(5):712–719. doi: 10.4158/EP11371.OR

Fig. 3.

Fig. 3

Glycemic outcomes in patients receiving neutral protamine Hagedorn (NPH) insulin (n = 60) or insulin glargine (n = 60) as basal insulin in a retrospective study of glucocorticoid-associated hyperglycemia. Panel A, Mean fasting blood glucose concentration. Panel B, Mean daily blood glucose concentration. Panel C, Median daily blood glucose concentration. Panel D, Mean number of hypoglycemic episodes per day. Error bars represent standard deviation.